Improvement of maximal & pain-free walking distances in patients w/ intermittent claudication, who do not have rest pain & evidence of peripheral tissue necrosis. Prevention of cerebral infarction recurrence (excluding cardiogenic cerebral embolism).
Patients at risk of bleeding from surgery or pathologic processes; thrombocytopenia. Patients w/ unstable angina pectoris, MI, or coronary intervention w/in last 6 mth; history of tachyarrhythmia. Periodically monitor WBC &/or platelet counts in long-term use. Concomitant use w/ antiplatelet or anticoagulants. May affect ability to drive & operate machinery. Severe hepatic & renal impairment. Pregnancy & lactation. Childn. Elderly.
Sign Out
